Brad D. Maxwell
11Patents
4h-index
80Co-inventors
59Inventor score
Filing activity: Apr 24, 2013 → Nov 8, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9688695B2 | Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor 4 (PAR4) inhibitors for treating platelet aggregation | Chemistry; Metallurgy | 9 | Active |
| US10047103B2 | Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor 4 (PAR4) inhibitors for treating platelet aggregation | Chemistry; Metallurgy | 8 | Active |
| US10428077B2 | Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor4 (PAR4) inhibitors for treating platelet aggregation | Chemistry; Metallurgy | 5 | Active |
| US11866446B2 | Inhibitors of APOL1 and methods of using same | Chemistry; Metallurgy | 4 | Active |
| US10822343B2 | Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor4 (PAR4) inhibitors for treating platelet aggregation | Chemistry; Metallurgy | 3 | Active |
| US11623924B2 | Modulators of alpha-1 antitrypsin | Chemistry; Metallurgy | 2 | Active |
| US11884672B2 | Modulators of alpha-1 antitrypsin | Chemistry; Metallurgy | 1 | Active |
| US12084452B2 | Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor 4 (PAR4) inhibitors for treating platelet aggregation | Chemistry; Metallurgy | 0 | Active |
| US9580422B2 | Isotopically labeled triazolopyridine 11-beta hydroxysteroid dehydrogenase type I inhibitors | Chemistry; Metallurgy | 0 | Active |
| US12331057B2 | Modulators of alpha-1 antitrypsin | Chemistry; Metallurgy | 0 | Active |
| US12421249B2 | Inhibitors of APOL1 and methods of using same | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.